✦ LIBER ✦

The Gly2019Ser mutation inLRRK2is not fully penetrant in familial Parkinson's disease: the GenePD study

✍ Scribed by Jeanne C Latourelle; Mei Sun; Mark F Lew; Oksana Suchowersky; Christine Klein; Lawrence I Golbe; Margery H Mark; John H Growdon; G Frederick Wooten; Ray L Watts; Mark Guttman; Brad A Racette; Joel S Perlmutter; Anwar Ahmed; Holly A Shill; Carlos Singer; Stefano Goldwurm; Gianni Pezzoli; Michela Zini; Marie H Saint-Hilaire; Audrey E Hendricks; Sally Williamson; Michael W Nagle; Jemma B Wilk; Tiffany Massood; Karen W Huskey; Jason M Laramie; Anita L DeStefano; Kenneth B Baker; Ilia Itin; Irene Litvan; Garth Nicholson; Alastair Corbett; Martha Nance; Edward Drasby; Stuart Isaacson; David J Burn; Patrick F Chinnery; Peter P Pramstaller; Jomana Al-hinti; Anette T Moller; Karen Ostergaard; Scott J Sherman; Richard Roxburgh; Barry Snow; John T Slevin; Franca Cambi; James F Gusella; Richard H Myers

Book ID: 115021962
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 244 KB
Volume: 6
Category: Article
ISSN: 1741-7015
DOI: 10.1186/1741-7015-6-32

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Striatal dopamine transporter binding in

Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation

✍ Ioannis U. Isaias; Riccardo Benti; Stefano Goldwurm; Michela Zini; Roberto Cilia 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

We measured striatal dopamine transporter binding using [(123)I]ioflupane and SPECT in patients with Parkinson's disease associated with the LRRK2 (PARK8) Gly2019Ser gene mutation (LRRK2-PD) and in gene-negative patients with idiopathic Parkinson's disease (IPD) of comparable disease duration and se

Huntington CAG repeat size does not modi

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The genePD study

✍ N. Ahmad Aziz; Raymund A.C. Roos 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 1 views

Huntington CAG repeat size does not modi

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study

✍ Christopher F. McNicoll; Jeanne C. Latourelle; Marcy E. MacDonald; Mark F. Lew; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract The ATP/ADP ratio reflects mitochondrial function and has been reported to be influenced by the size of the Huntington disease gene (__HD__) repeat. Impaired mitochondrial function has long been implicated in the pathogenesis of Parkinson's disease (PD), and therefore, we evaluated the

The Asp620asn mutation in VPS35 is not a

The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease

✍ Ilaria Guella; Giulia Soldà; Roberto Cilia; Gianni Pezzoli; Rosanna Asselta; Ste 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

The α-synuclein Ala53Thr mutation is not

The α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases

✍ Jenny Vaughan; Alexandra Durr; Johann Tassin; Benjamin Bereznai; Thomas Gasser; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

The Ile93Met mutation in the ubiquitin c

The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

✍ B.Sanjay Harhangi; Matthew J. Farrer; Sarah Lincoln; Vincenzo Bonifati; Giuseppe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 83 KB